SM-130,686 is a potent, orally-active agonist of the ghrelin growthhormonesecretagoguereceptor (GHSR) and growthhormonesecretagogue. It has around half the potency of the endogenous agonist ghrelin as a stimulator of growthhormone release.
PF-04628935 is a potent antagonist inverse agonist of the ghrelin receptor, growthhormonesecretagoguereceptor 1a (GHS-R1a) with an IC50 of 4.6 nM. PF-04628935 is orally bioavailable and brain penetrant.
BMS-604992 (EX-1314) dihydrochloride is a selective and orally active small-molecule agonist of the growthhormonesecretagoguereceptor (GHSR). It exhibits high-affinity binding (k i = 2.3 nM) and potent functional activity (EC 50 = 0.4 nM). Furthermore, BMS-604992 dihydrochloride has been shown to stimulate food intake in rodents.
BMS-604992 (EX-1314) free base is a selective, orally active small-molecule growthhormonesecretagoguereceptor (GHSR) agonist. It exhibits high-affinity binding (k i = 2.3 nM) and potent functional activity (EC 50 = 0.4 nM). Moreover, BMS-604992 free base has the ability to stimulate food intake in rodents.
Relamorelin (RM-131) acetate is a pentapeptide ghrelin analog that acts as a selective agonist for the ghrelin growthhormonesecretagoguereceptor (GHSR). It exhibits a high affinity for the GHS-1a receptor, with a Ki value of 0.42 nM. Notably, Relamorelin acetate can cross the blood-brain barrier and target the central nervous system. This compound effectively increases growthhormone levels and promotes faster gastric emptying. Due to these properties, Relamorelin acetate holds promise for its potential applications in research related to cachexia, gastroparesis, and gastric intestinal dysmobility disorders [4] [5].
AZ-GHS-22 is an inverse agonist of the growthhormonesecretagoguereceptor 1a (GHS-R1a), which is also known as the ghrelin receptor.1It binds to GHS-R1a with an IC50value of 0.77 nM. AZ-GHS-22 decreases food intake in mice by 54% in the first two hours after administration of a 100 mg/kg dose. 1.McCoull, W., Barton, P., Brown, A.J.H., et al.Identification, optimization, and pharmacology of acylurea GHS-R1a inverse agonistsJ. Med. Chem.57(14)6128-6140(2014)
Ghrelin is an endogenous ligand for the growthhormonesecretagoguereceptor that stimulates food intake and transduces signals to hypothalamic regulatory nuclei that control energy homeostasis. JMV3002 is a potent ghrelin receptor antagonist with an IC50 value of 1.1 nM in vitro. At 80 μg kg, JMV3002 inhibits hexarelin-stimulated food intake by as much as 98% in rats. JMV3002 alone does not elicit growthhormone release nor does it inhibit hexarelin-stimulated growthhormone secretion when tested in infant rats at a dose of 160 μg kg.
Capromorelin, a member of the growthhormonesecretagogue (GHS) class of drugs, is a ghrelin receptor agonist and a novel therapy for stimulation of appetite in dogs with Ki value of 7 nM for hGHS-R1a and EC50 value of 3 nM for rat pituicyte. Capromorelin